Literature DB >> 32673475

Predictive Signatures of 19 Antibiotic-Induced Escherichia coli Proteomes.

Yanbao Yu1, Aubrie O'Rourke2, Yi-Han Lin1, Harinder Singh1, Rodrigo Vargas Eguez1, Sinem Beyhan2, Karen E Nelson1,2.   

Abstract

Identifying the mode of action (MOA) of antibacterial compounds is the fundamental basis for the development of new antibiotics, and the challenge increases with the emerging secondary and indirect effect from antibiotic stress. Although various omics-based system biology approaches are currently available, enhanced throughput, accuracy, and comprehensiveness are still desirable to better define antibiotic MOA. Using label-free quantitative proteomics, we present here a comprehensive reference map of proteomic signatures of Escherichia coli under challenge of 19 individual antibiotics. Applying several machine learning techniques, we derived a panel of 14 proteins that can be used to classify the antibiotics into different MOAs with nearly 100% accuracy. These proteins tend to mediate diverse bacterial cellular and metabolic processes. Transcriptomic level profiling correlates well with protein expression changes in discriminating different antibiotics. The reported expression signatures will aid future studies in identifying MOA of unknown compounds and facilitate the discovery of novel antibiotics.

Entities:  

Keywords:  Escherichia coli; antibiotics; label-free; mode of action (MOA); quantitative proteomics; suspension trapping (S-Trap)

Mesh:

Substances:

Year:  2020        PMID: 32673475     DOI: 10.1021/acsinfecdis.0c00196

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  2 in total

1.  Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis.

Authors:  Madita Brauer; Jennifer Herrmann; Daniela Zühlke; Rolf Müller; Katharina Riedel; Susanne Sievers
Journal:  Gut Pathog       Date:  2022-01-06       Impact factor: 4.181

2.  Identification of Antibiotic Resistance Proteins via MiCId's Augmented Workflow. A Mass Spectrometry-Based Proteomics Approach.

Authors:  Gelio Alves; Aleksey Ogurtsov; Roger Karlsson; Daniel Jaén-Luchoro; Beatriz Piñeiro-Iglesias; Francisco Salvà-Serra; Björn Andersson; Edward R B Moore; Yi-Kuo Yu
Journal:  J Am Soc Mass Spectrom       Date:  2022-05-02       Impact factor: 3.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.